Proposed Information Collection Activity; Comment Request, 54053-54054 [05-18045]
Download as PDF
<![CDATA[
54053
Federal Register / Vol. 70, No. 176 / Tuesday, September 13, 2005 / Notices
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Cycle 7 of the National Survey of
Family Growth (NSFG–7)—OMB No.
0920–0314—Reinstatement with
change—National Center for Health
Statistics (NCHS), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The National Survey of Family
Growth (NSFG) has been conducted
periodically since 1973 by the CDC’s
National Center for Health Statistics.
The first five cycles were based on inperson interviews with national samples
of women 15–44 years of age. Cycle 6,
in 2002, was based on interviews with
a national sample of 12,571 persons—
4,928 men and 7,643 women ages 15–
44. Interviews provided national
estimates of behavior related to birth
and pregnancy rates; marriage, divorce,
and adoption; behavior related to the
risk of Human Immunodeficiency Virus
(HIV) and other sexually transmitted
diseases; attitudes toward marriage,
childbearing, and parenthood; and
men’s and women’s roles in raising
children.
While the content of Cycle 7 will be
similar to that of Cycle 6, the
interviewing will be conducted over a 4year period rather than being completed
in one year, as in previous cycles. This
continuous interviewing design is
intended to reduce costs, increase
efficiency, and contribute to continuous
improvement in the collection,
processing, and dissemination of the
data. Sample size is expected to increase
from 12,571 in Cycle 6 to 17,400 total
in the 4 years of data collection in Cycle
7. For this cycle, the ‘‘Pretest’’ will be
conducted initially in the first 8 weeks
of interviewing and, if no problems are
found, those weeks will become part of
the Main Study. If operational problems
are found in that period, they will be
corrected, and the ‘‘Main Study’’ will
begin at that point. The burden table
represents the survey collection
averaged over the first three years of
data collection.
Users of the NSFG include: the
National Institutes of Health’s National
Institute of Child Health and Human
Development and the Office of
Population Affairs; CDC’s NCHS,
Division of Reproductive Health,
National Center for Chronic Disease
Prevention and Health
Promotion(NCCDPHP); Divisions of
HIV/AIDS Prevention, National Center
for HIV, STD, & TB Prevention
(NCHSTP); and the Department’s Office
of the Assistant Secretary for Planning
and Evaluation, and Administration for
Children and Families. There is no cost
to respondents other than their time to
participate.
ESTIMATED AVERAGE ANNUALIZED HOUR BURDEN
Responses
per respondent
Number of
respondents
Survey and type of respondents
Avg. burden
per response
(in hours)
Total burden
hours.
Pretest
Screener ..........................................................................................................
Males ...............................................................................................................
Females ...........................................................................................................
Main Study
Screener ..........................................................................................................
Males ...............................................................................................................
Females ...........................................................................................................
403
109
133
1
1
1
5/60
1
1.33
34
109
177
7,250
1,957
2,393
1
1
1
5/60
1
1.33
604
1,957
3,183
Total ..........................................................................................................
........................
........................
........................
6,064
Betsey Dunaway,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 05–18056 Filed 9–12–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Proposed Projects:
VerDate Aug<18>2005
16:06 Sep 12, 2005
Jkt 205001
Title: Financial Status Reporting Form
for the Program of State Council on
Developmental Disabilities.
OMB No.: 098––0212.
Description: For the program of the
State Council on Developmental
Disabilities, funds are awarded to State
agencies contingent on fiscal
requirements in Subtitle B of the
Developmental Disabilities Assistance
and Bill of Rights Act. The SF–269,
ordinarily mandated in the revised OMB
Circular A–102, provides no accounting
breakouts necessary for proper
stewardship. Consequently, the
proposed streamlined form will
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
substitute for the SF–269 and will allow
compliance monitoring and proactive
compliance maintenance and technical
assistance.
Respondents: State Councils and
Designated State Agencies.
E:\FR\FM\13SEN1.SGM
13SEN1
54054
Federal Register / Vol. 70, No. 176 / Tuesday, September 13, 2005 / Notices
ANNUAL BURDEN ESTIMATES
Instrument
Number of
respondents
Number of responses per
respondent
Average burden hours per
response
Total burden
hours
Financial Status Reporting Form for program of State Council on Developmental Disabilities ........................................................................................
55
1
8
440
Estimated Total Annual Burden
Hours: 440.
In compliance with the requirements
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. E-mail address:
grjohnson@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Dated: September 7, 2005.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 05–18045 Filed 9–12–05; 8:45 am]
BILLING CODE 4184–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2005N–0354]
Consumer-Directed Promotion of
Regulated Medical Products; Public
Hearing
AGENCY:
Food and Drug Administration,
HHS.
VerDate Aug<18>2005
16:06 Sep 12, 2005
Jkt 205001
Notice of public hearing; request
for comments.
ACTION:
SUMMARY: The Food and Drug
Administration (FDA) is announcing a
public hearing on direct-to-consumer
(DTC) promotion of regulated medical
products, including prescription drugs
for humans and animals, vaccines,
blood products, and medical devices.
FDA is particularly interested in hearing
the views of individuals and groups
most affected by DTC promotion,
including consumers, patients,
caregivers, health professionals
(physicians, physicians’ assistants,
dentists, nurses, pharmacists,
veterinarians, and veterinarian
technicians) managed care
organizations, and insurers, as well as
the regulated industry. FDA is seeking
input on a number of specific questions,
but is interested in any other pertinent
information participants in the hearing
would like to share.
Dates and Times: The public hearing
will be held on November 1 and 2, 2005,
from 9 a.m. to 5 p.m. Submit written or
electronic notices of participation by
close of business on October 11, 2005.
Written and electronic comments will
be accepted until February 28, 2006.
Location: The public hearing will be
held at the National Transportation
Safety Board Boardroom and Conference
Center, 429 L’Enfant Plaza, SW.,
Washington, DC 20594, 202–314–6421;
Metro: L’Enfant Plaza station on the
green, yellow, blue, and orange lines;
see: https://ntsb.gov/events/
newlocation.htm. (FDA has verified the
Web site address, but FDA is not
responsible for any changes to the Web
site after this document publishes in the
Federal Register.)
Addresses: Written or electronic
notices of participation should be
submitted to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852, or on the
Internet at https://
www.accessdata.fda.gov/scripts/oc/
dockets/meetings/meetingdocket.cfm.
Comments about the meeting or
comments after the meeting should be
submitted to https://www.fda.gov/
dockets/ecomments. Written or
electronic comments can be submitted
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
to https://www.fda.gov/oc/dockets/
ecomments. A consolidated list of all
documents and other information
related to the public hearing, such as the
Federal Register notice, the agenda,
public comments, and transcripts will
be posted with their links, as the
documents are made available, on the
Center for Drug Evaluation and Research
(CDER) Web site at https://www.fda.gov/
cder/ddmac.
For further information contact: Rose
Cunningham, Center for Drug
Evaluation and Research (HFD–006),
Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20852,
301–443–5595, e-mail:
cunninghmar@cder.fda.gov.
For registration to attend and/or to
participate in the meeting: Seating at the
hearing is limited. People interested in
attending the meeting should register at
https://www.accessdata.fda.gov/scripts/
oc/dockets/meetings/
meetingdocket.cfm. Registration is free
and will be accepted on a first-come,
first-served basis.
The procedures governing the hearing
are found in part 15 (21 CFR part 15).
Anyone wishing to make an oral
presentation during the hearing must
state this intention on the registration
form (see Addresses). To participate,
submit your name, title, business
affiliation, address, telephone and fax
numbers, and e-mail address.
A written statement also should be
submitted at the time of registration for
each discussion question to be
addressed, with the names and
addresses of all individuals who plan to
participate, and the approximate time
requested for the presentation. The
agency requests that interested persons
and groups having similar interests
consolidate their comments and present
them through a single representative.
Individuals who have registered to make
an oral presentation will be notified of
the scheduled time for their
presentation prior to the hearing.
Depending on the number of
presentations, FDA may need to limit
the time allotted for each presentation.
FDA has identified questions and
subject matter of special interest in
section III of this document, but
presentations do not have to be limited
to those questions. Presenters should
E:\FR\FM\13SEN1.SGM
13SEN1
]]>Agencies
[Federal Register Volume 70, Number 176 (Tuesday, September 13, 2005)]
[Notices]
[Pages 54053-54054]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-18045]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Proposed Information Collection Activity; Comment Request
Proposed Projects:
Title: Financial Status Reporting Form for the Program of State
Council on Developmental Disabilities.
OMB No.: 098--0212.
Description: For the program of the State Council on Developmental
Disabilities, funds are awarded to State agencies contingent on fiscal
requirements in Subtitle B of the Developmental Disabilities Assistance
and Bill of Rights Act. The SF-269, ordinarily mandated in the revised
OMB Circular A-102, provides no accounting breakouts necessary for
proper stewardship. Consequently, the proposed streamlined form will
substitute for the SF-269 and will allow compliance monitoring and
proactive compliance maintenance and technical assistance.
Respondents: State Councils and Designated State Agencies.
[[Page 54054]]
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Instrument Number of responses per hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
Financial Status Reporting Form for program 55 1 8 440
of State Council on Developmental
Disabilities...............................
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: 440.
In compliance with the requirements of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Administration for Children and
Families is soliciting public comment on the specific aspects of the
information collection described above. Copies of the proposed
collection of information can be obtained and comments may be forwarded
by writing to the Administration for Children and Families, Office of
Administration, Office of Information Services, 370 L'Enfant Promenade,
SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. E-mail
address: grjohnson@acf.hhs.gov. All requests should be identified by
the title of the information collection.
The Department specifically requests comments on: (a) Whether the
proposed collection of information is necessary for the proper
performance of the functions of the agency, including whether the
information shall have practical utility; (b) the accuracy of the
agency's estimate of the burden of the proposed collection of
information; (c) the quality, utility, and clarity of the information
to be collected; and (d) ways to minimize the burden of the collection
of information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Consideration will be given to comments and suggestions submitted
within 60 days of this publication.
Dated: September 7, 2005.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 05-18045 Filed 9-12-05; 8:45 am]
BILLING CODE 4184-01-M
